# Merck & Co., Inc.  Share Price Target ‘$142.79’, now 12.2% Upside Potential

- Link: https://www.directorstalkinterviews.com/merck-co.inc.share-price-target-142.79-now-12.2-upside-potential/4121164738
- Published: 2024-07-12T15:02:30+01:00
- Author: Charlotte Edwards

**Merck & Co., Inc.** with ticker code (MRK) now have 25 confirmed analysts covering
the stock with the consensus suggesting a rating of ‘buy’. The target price High/
Low ranges between $155.00 and $124.50 and has a mean share price target at $142.79.(
at the time of writing). Now with the previous closing price of $127.30 this indicates
there is a potential upside of 12.2%. The 50 day MA is $129.04 and the 200 day MA
is $118.56. The market cap for the company is 326.66B. The stock price for the company
is currently $128.97 USD

 The potential market cap would be $366,404,402,389 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 143.3, revenue per share of $24.22
and a 10.26% return on assets.

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions
through its prescription medicines, including biological therapies, vaccines and
animal health products. It operates through two segments: Pharmaceutical and Animal
Health. The Pharmaceutical segment includes human health pharmaceutical and vaccine
products. Its human health pharmaceutical products consist of therapeutic and preventive
agents, generally sold by prescription for the treatment of human disorders. The
Company sells these human health pharmaceutical products primarily to drug wholesalers
and retailers, hospitals, government agencies and managed healthcare providers, 
such as health maintenance organizations. The Animal Health segment develops, manufactures
and markets a range of veterinary pharmaceutical and vaccine products, as well as
health management solutions and services for the prevention, treatment and control
of disease in all major livestock and companion animal species.

Share on: